A comprehensive analysis of LINC00958 as a prognostic biomarker for head and neck squamous cell carcinoma
International Journal of Oral and Maxillofacial Surgery · 2024
DOI: 10.1016/j.ijom.2023.09.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Oral and Maxillofacial Surgery, 2024. Verfasst von R Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Maxillofacial and Head and Neck Oncology, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of M…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, RNA, Long Noncoding, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
This work focused on exploring whether the long intergenic non-protein coding RNA LINC00958 is associated with the prognosis of head and neck squamous cell carcinoma (HNSCC). Associations of the LINC00958 expression level with clinicopathological features of HNSCC were investigated by logistic regression and Wilcoxon signed-rank test. The Kaplan-Meier method was applied to evaluate patient survival. Clinical data and expression profiles were obtained from The Cancer Genome Atlas (TCGA). Associations of patient clinical characteristics with overall survival (OS), progression-free interval (PFI), and disease-specific survival (DSS) were assessed by univariate and multivariate analysis using the Cox proportional hazard model. Immune cell infiltration analysis and gene set enrichment analysis (GSEA) were applied to determine any significant effects of LINC00958. High LINC00958 expression was related to early pT stage (P < 0.01), primary therapy outcome (P < 0.01), HPV status (P < 0.001), lymphovascular invasion (P < 0.001), and perineural invasion (P < 0.01). The receiver operating characteristic curve showed strong prognostic power for LINC00958 (area under curve = 0.886). High LINC00958 expression predicted poor OS (P = 0.007), DSS (P = 0.036), and PFI (P = 0.040). LINC00958 was related to signalling pathways and the infiltration of certain immune cells. miR-27b-5p was significantly associated with LINC00958, and downstream NT5E predicted poor survival in HNSCC cases. LINC00958 may affect the prognosis by regulating NT5E via miR-27b-5p, and could serve as a possible factor to predict the prognosis of HNSCC, especially oral squamous cell carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Maxillofacial and Head and Neck Oncology, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Center of Stomatology, National Cli…
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
- Qingdao Stomatological Hospital Affiliated to Qingdao University, Qingdao, Shandong Province, China.
- Center of Oral Medicine, Qingdao Municipal Hospital, Qingdao, Shandong Province, China.
Zitieren
APA
Li, R., An, P., Lin, X., Liu, X., Zhao, L., & He, Y. (2024). A comprehensive analysis of LINC00958 as a prognostic biomarker for head and neck squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery. https://doi.org/10.1016/j.ijom.2023.09.014
Vancouver
Li R, An P, Lin X, Liu X, Zhao L, He Y. A comprehensive analysis of LINC00958 as a prognostic biomarker for head and neck squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery. 2024. doi:10.1016/j.ijom.2023.09.014
BibTeX
@article{Li2024,
author = {Li, R and An, P and Lin, X and Liu, X and Zhao, L and He, Y},
title = {A comprehensive analysis of LINC00958 as a prognostic biomarker for head and neck squamous cell carcinoma},
journal = {International Journal of Oral and Maxillofacial Surgery},
year = {2024},
doi = {10.1016/j.ijom.2023.09.014}
}
EUVIMED